21 results on '"Jayaram, Kala"'
Search Results
2. Safe and persistent growth-promoting effects of vosoritide in children with achondroplasia: 2-year results from an open-label, phase 3 extension study
3. Persistent and Stable Growth Promoting Effects of Vosoritide in Children With Achondroplasia for up to 2 Years: Results From the Ongoing Phase 3 Extension Study
4. SAT-LB18 A Randomized Controlled Trial of Vosoritide in Children With Achondroplasia
5. Pharmacokinetics and Exposure–Response of Vosoritide in Children with Achondroplasia
6. A study on the safety and efficacy of reveglucosidase alfa in patients with late-onset Pompe disease
7. Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A
8. P338: Objectives and design of the Acorn Study: A non-interventional study evaluating long-term safety in achondroplasia patients treated with vosoritide
9. P193: Persistent growth-promoting effects of vosoritide in children with achondroplasia for up to 3.5 years: Update from phase 3 extension study*
10. Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A
11. Vosoritide treatment accelerates bone growth in children with achondroplasia
12. Pharmacokinetics and Exposure–Response of Vosoritide in Children with Achondroplasia
13. Vosoritide for children with achondroplasia: a 60-month update from an ongoing phase 2 clinical trial
14. A Randomized Controlled Trial of Vosoritide in Children with Achondroplasia
15. Vector Shedding and Blood Biodistribution in Patients with Severe Hemophilia a Following Administration of Valoctocogene Roxaparvovec
16. Once-daily, subcutaneous vosoritide therapy in children with achondroplasia: a randomised, double-blind, phase 3, placebo-controlled, multicentre trial
17. C-Type Natriuretic Peptide Analogue Therapy in Children with Achondroplasia
18. Additional file 1: of A study on the safety and efficacy of reveglucosidase alfa in patients with late-onset Pompe disease
19. Additional file 3: of A study on the safety and efficacy of reveglucosidase alfa in patients with late-onset Pompe disease
20. Additional file 2: of A study on the safety and efficacy of reveglucosidase alfa in patients with late-onset Pompe disease
21. eP151 - Vosoritide for children with achondroplasia: a 60-month update from an ongoing phase 2 clinical trial.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.